Search clinical trials for: Bioequivalence Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets fasting conditions

Total 477581 results

Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions

Healthy
EMS

Not yet recruiting

Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control

Essential Arterial Hypertension
Boehringer Ingelheim

Completed

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

Hypertension

United States
Ain Shams University

Unknown

Addition of Azithromycin to Cefazolin Will Reduce Post CS Infections More Than Cefazolin Only.

Randomized Controll Trial

Egypt
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

Healthy

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fasting Conditions

Healthy
Boehringer Ingelheim

Completed

Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension

Hypertension

Japan
Fundación Pública Andaluza para la gestión de la...

Recruiting

Preoperative Carbohydrate Loading for Enhancing Recovery After Radical Cystectomy

Surgery | Anesthesia | Urologic Cancer

Spain
CMN "20 de Noviembre"

Unknown

Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients

COVID-19

Mexico
Actavis Inc.

Completed

A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions

Healthy

Canada
Mylan Pharmaceuticals Inc

Completed

Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg

Healthy

United States
GlaxoSmithKline

Completed

A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults

Gastrointestinal Diseases

Egypt
Pfizer

Completed

A Study to Evaluate the Efficacy and Safety of Quinapril or Quinapril Plus Hydrochlorothiazide in Patients With Mild to Moderate Hypertension

Hypertension

Turkey
Actavis Inc.

Completed

A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Non-fasting Conditions

Healthy

Canada
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition

Fasting State

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fasting Conditions

Healthy

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions

Fasting

India
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Aliskiren in Pediatric Hypertensive Patients 6-17 Years of Age

Hypertension

United States, Belgium, Hungary, Turkey, Guatemala, Slovakia, Germany, Puerto Rico, Poland
HealthPartners Institute

Completed

Microbiome Changes in Severe Burns (Microbiome)

Burns | Burns Greater Than 20% BSAB

United States
Teva Pharmaceuticals USA

Completed

Leflunomide 20 mg Tablets Under Fasting Conditions

Healthy

United States
Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults

Solid Tumor | Idiopathic Pulmonary Fibrosis(IPF)

China
New World Medical, Inc.

Not yet recruiting

An Extension Trial for Patients With Open-Angle Glaucoma Who Participated in the DF6-CL-20-01 Protocol.

Intraocular Pressure | Open Angle Glaucoma

Costa Rica
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fasting Conditions

Healthy

United States
HK inno.N Corporation

Completed

The Food Effect on Pharmacokinetics and Safety of Fixed-dose Combination of CJ-30056 in Healthy Male Subjects

Food Effect Study of CJ-30056 20mg/500mg

Korea, Republic of
Bandim Health Project

Completed

Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria

Malaria | Effectiveness

Guinea-Bissau
Ostfold Hospital Trust

Unknown

Quadratus Lumborum Block Versus Transversus Abdominis Plane Block in Patients Undergoing Left Hemicolectomy

Pain, Postoperative | Surgery | Colon Neoplasm

Norway
CMN "20 de Noviembre"

Active, not recruiting

Estrogen Therapy in Non-severe COVID-19 Patients

Covid-19

Mexico
CMN "20 de Noviembre"

Completed

Distal Transradial Access for Coronary Angiography and Percutaneous Coronary Intervention.

Coronary Artery Disease

Mexico
W.J. Pasman

Completed

Appetite Suppression Trial With Polydextrose

Body Weight | Non-restrained Eaters

Netherlands
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Quinapril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Accuretic™ Tablets 20 mg/25 mg

Healthy

United States
Organon and Co

Completed

BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333) (EASE)

Hypertension
Novartis Pharmaceuticals

Completed

A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia

Cytopaenia

Japan
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions

Fed

India
NYU Langone Health

Completed

A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection

COVID-19

United States
Teva Pharmaceuticals USA

Completed

Leflunomide 20 mg Tablets, Non-Fasting

Healthy

United States
Azienda ULSS di Verona e Provincia
Universita di Verona; FONDAZIONE CARIVERONA

Completed

Physical Co-morbidity, Poor Health Behaviour and Health Promotion in Verona Patients With Functional Psychoses (PHYSICO-DSM-VR)

Psychotic Disorders | Bipolar Disorders

Italy
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg

Healthy

United States
Seoul National University Hospital

Completed

A Study to Investigate the Effect of Urine Acid-base Disequilibrium on the Pharmacokinetics of Captopril

Hypertension

Korea, Republic of
Hebei Senlang Biotechnology Inc., Ltd.
Tongji Hospital

Recruiting

To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors

19 and 22+ B Cell Hematologic Tumors | 19 and 20+ B Cell Hematologic Tumors

China
Genuine Research Center, Egypt
Hikma Pharma

Completed

Bioequivalence Study of Empagliflozin & Metformin HCL From Empagliform 12.5/1000 mg F.C.T (Hikma Pharma, Egypt) and Synjardy 12.5/1000 mg F.C.T (Boehringer Ingelheim International GmbH, Germany)

Healthy

Egypt
New World Medical, Inc.

Not yet recruiting

Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma

POAG

Costa Rica, Honduras, Mexico
GlaxoSmithKline

Completed

Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions

Gastrointestinal Diseases

Egypt
Hospital Universitari Son Dureta

Unknown

Effectiveness of Dipeptide N (2)-L-Alanyl-L-Glutamine in Trauma ICU Patients: Pilot, Prospective, Randomized and Double Blind Study. (GluTrac)

Trauma ICU Patients

Spain
Omega Ophthalmics

Active, not recruiting

Clinical Investigation of Omega Refractive Capsule, Model VI (ORCVI)

Cataract

Costa Rica
Omega Ophthalmics

Completed

Comparison of Gemini III Rev 2 Implanted in Conjunction With an Approved IOL vs Eyes Implanted With an Approved IOL

Cataract

Costa Rica
Menarini Group
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential Hypertension

Hypertension

Poland, Germany, Israel, Romania, Italy, Denmark, Czechia, Croatia
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

Healthy

India
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions

Healthy

United States

3

Subscribe